Predicting PD-L1 expression status in patients with non-small cell lung cancer using [ 18 F]FDG PET/CT radiomics.
Xiaoqian ZhaoYan ZhaoJingmian ZhangZhaoqi ZhangLihua LiuXinming ZhaoPublished in: EJNMMI research (2023)
PET/CT-based radiomics features demonstrated strong potential in predicting PD-L1 expression status and thus could be used to preselect patients who may benefit from PD-1/PD-L1-based immunotherapy.